510(k) K221007
K221007 is an FDA 510(k) premarket notification submitted by Roche Molecular Systems, Inc. for the device "cobas HCV". The FDA issued a decision of Substantially Equivalent on Nov 4, 2022. The device falls under product code MZP (Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus), a Class II device regulated under 21 CFR 866.3170. Roche Molecular Systems, Inc. has 54 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 4, 2022
- Date Received
- Apr 5, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
- Device Class
- Class II
- Regulation Number
- 866.3170
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Roche Molecular Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.